rivastigmine tartrate

Generic: rivastigmine tartrate

Labeler: major pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name rivastigmine tartrate
Generic Name rivastigmine tartrate
Labeler major pharmaceuticals
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

rivastigmine tartrate 1.5 mg/1

Manufacturer
Major Pharmaceuticals

Identifiers & Regulatory

Product NDC 0904-7107
Product ID 0904-7107_65cfb382-8f01-4ee8-8235-8ce2f5d3beec
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204572
Listing Expiration 2026-12-31
Marketing Start 2016-03-25

Pharmacologic Class

Classes
cholinesterase inhibitor [epc] cholinesterase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 09047107
Hyphenated Format 0904-7107

Supplemental Identifiers

RxCUI
314214
UNII
9IY2357JPE

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name rivastigmine tartrate (source: ndc)
Generic Name rivastigmine tartrate (source: ndc)
Application Number ANDA204572 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 1.5 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (0904-7107-61) / 1 CAPSULE in 1 BLISTER PACK
source: ndc

Packages (1)

Ingredients (1)

rivastigmine tartrate (1.5 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "65cfb382-8f01-4ee8-8235-8ce2f5d3beec", "openfda": {"unii": ["9IY2357JPE"], "rxcui": ["314214"], "spl_set_id": ["39aadc39-0f4f-44f7-88de-83a0ea2ac332"], "manufacturer_name": ["Major Pharmaceuticals"]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (0904-7107-61)  / 1 CAPSULE in 1 BLISTER PACK", "package_ndc": "0904-7107-61", "marketing_start_date": "20160325"}], "brand_name": "Rivastigmine Tartrate", "product_id": "0904-7107_65cfb382-8f01-4ee8-8235-8ce2f5d3beec", "dosage_form": "CAPSULE", "pharm_class": ["Cholinesterase Inhibitor [EPC]", "Cholinesterase Inhibitors [MoA]"], "product_ndc": "0904-7107", "generic_name": "Rivastigmine Tartrate", "labeler_name": "Major Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Rivastigmine Tartrate", "active_ingredients": [{"name": "RIVASTIGMINE TARTRATE", "strength": "1.5 mg/1"}], "application_number": "ANDA204572", "marketing_category": "ANDA", "marketing_start_date": "20160325", "listing_expiration_date": "20261231"}